Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance.
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance.
-
Narrated by:
-
By:
About this listen
Hitting this November month with a very relevant topic, Global Governance! In this episode, you can listen to an interview with had with Prof. Olivier Rubin, from Roskilde University in Denmark, about the social dimensions of AMR, and how AMR is a so-called “creeping crisis” globally. Olivier has years of experience researching slow-onset crisis such as famine and climate change, and has in the recent years worked intensively in AMR and the similarities and differences with such crises. Tune in to hear his insights!
In the news section, we update you on our very very busy month of November, and bring you a really important paper demonstrating the relationship between rifaximin use and daptomicin resistance in Enterococcus.
Check relevant links in the show notes here. Follow our updates on twitter/X & Bluesky with #theAMRstudio hashtag! Theme music by Henrik Niss.